The continued growth of the Internet, and its increasing pervasiveness in our lives, has many of us considering how we might incorporate Web-based avenues of communication in our practice. The ease and convenience of e-mail, for example, is tempting, but could also open up a Pandora's box. Does e-mail inherently pose new challenges that may not be an issue with phone dialogue or in-person discussion? Dr. Richard Friedman, professor of clinical psychiatry at Weill Cornell Medical College and a regular contributor to the New York Times, shares his experience with e-mail in his practice and a few tips for those who use or are contemplating Web communication for their practice. Dr. Cathleen Margolin hosts.
Payoffs and Pitfalls of E-Communication in Psychiatry

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The continued growth of the Internet, and its increasing pervasiveness in our lives, has many of us considering how we might incorporate Web-based avenues of communication in our practice. The ease and convenience of e-mail, for example, is tempting, but could also open up a Pandora's box. Does e-mail inherently pose new challenges that may not be an issue with phone dialogue or in-person discussion? Dr. Richard Friedman, professor of clinical psychiatry at Weill Cornell Medical College and a regular contributor to the New York Times, shares his experience with e-mail in his practice and a few tips for those who use or are contemplating Web communication for their practice. Dr. Cathleen Margolin hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Bridging Distances in PAH: Bringing Best Practices to the People Through Telementoring
Updates From the 7th World Symposium Task Force
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
HF Management for Patients with Comorbid Conditions
Pulmonary Hypertension Management: Practice Trends and Updates
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Bladders, Breakthroughs, and Bold New Therapies: Key Updates at AUA 2025
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?